Adam R Kalbermatten bought $101K of KORU Medical Systems, Inc. (KRMD) stock

Adam R Kalbermatten, Chief Commercial Officer of KORU Medical Systems, Inc. (KRMD), bought 32,000 shares of KRMD stock worth $101K, per an SEC Form 4 filed Sep 9, 2026.

It was an open-market purchase.

The trade happened on Sep 8, 2026, 1 day before it was made public.

KRMD has moved +1.9% since the trade date, from $3.17 to $3.23 (Sep 21, 2026 close).